Subject:

Imatinib   New Search


View on DBpedia    View on Wikipedia
Top related subjects:
 Chronic myelogenous leukemia Tyrosine kinase Gene Myeloid tissue Mesylate Dasatinib Sunitinib Messenger RNA Kinase Gastrointestinal stromal tumor Imatinib Tyrosine-kinase inhibitor Growth factor Estrogen receptor Enzyme inhibitor Chemotherapy Protein DNA Polymerase chain reaction Acid Acute myeloid leukemia Haematopoiesis Hematopoietic stem cell Bone marrow GSTP1 Zygosity Vinca alkaloid Nilotinib Carcinoma Sorafenib Progression-free survival Western blot Apoptosis Phosphorylation CD117 Gastrointestinal tract Sarcoma Rectum Muscular layer
RELATED SUBJECTS:
The publications listed also have these subjects

Chronic myelogenous leukemia  15 times
Tyrosine kinase  10 times
Gene  7 times
Myeloid tissue  4 times
Dasatinib  4 times
Sunitinib  3 times
Messenger RNA  3 times
Kinase  3 times
Gastrointestinal stromal tumor  3 times
Chemotherapy  3 times
Bone marrow  3 times
Acute myeloid leukemia  3 times
Tyrosine  2 times
Targeted therapy  2 times
Syndrome  2 times
Splenomegaly  2 times
Rectum  2 times
Radiation therapy  2 times
Progression-free survival  2 times
Polymerase  2 times
Neoadjuvant therapy  2 times
Multivariate analysis  2 times
Mouse  2 times
Metastasis  2 times
Melanoma  2 times
Mathematical optimization  2 times
Linkage disequilibrium  2 times
Leukemia  2 times
Immunotherapy  2 times
Hematopoietic stem cell  2 times
Enzyme inhibitor  2 times
DNA sequencing  2 times
Cytogenetics  2 times
Clinical trial  2 times
Chain reaction  2 times
Capecitabine  2 times
CT scan  2 times
CD34  2 times
Blood plasma  2 times
Biopsy  2 times
Apoptosis  2 times
Anorexia nervosa  2 times
Zygosity  1 time
Xenotransplantation  1 time
White blood cell  1 time
Western blot  1 time
Virtual screening  1 time
Tyrosine-kinase inhibitor  1 time
Trastuzumab  1 time
Time point  1 time
Thrombocytopenia  1 time
Therapeutic drug monitoring  1 time
Tamoxifen  1 time
T-cell receptor  1 time
Standard deviation  1 time
Small interfering RNA  1 time
Single-nucleotide polymorphism  1 time
Sequence homology  1 time
Sanger sequencing  1 time
Rituximab  1 time
Real-time polymerase chain reaction  1 time
RNA  1 time
Proton  1 time
Protein structure  1 time
Protein kinase B  1 time
Protein  1 time
Prostate-specific antigen  1 time
Prostate cancer  1 time
Propofol  1 time
Polymer  1 time
Polish language  1 time
Photon  1 time
Phosphorylation  1 time
Phosphate  1 time
Philadelphia  1 time
Phase diagram  1 time
Pharmacokinetics  1 time
Pancreas  1 time
PH  1 time
P53  1 time
P-glycoprotein  1 time
Oxidative phosphorylation  1 time
Optimal control  1 time
Oncolytic virus  1 time
Oncology  1 time
Nivolumab  1 time
Neutropenia  1 time
Mutation  1 time
Multiplex polymerase chain reaction  1 time
Molecular dynamics  1 time
Metabolomics  1 time
Metabolism  1 time
Medical ultrasound  1 time
Medicaid  1 time
Mechanistic target of rapamycin  1 time
Mast cell  1 time
Magnetic resonance imaging  1 time
Lymphadenopathy  1 time
Leukopenia  1 time
Leukocytosis  1 time
Laparotomy  1 time
Karyotype  1 time
Japan  1 time
Jainism  1 time
Ipilimumab  1 time
Intron  1 time
International law  1 time
Interferon  1 time
Incremental cost-effectiveness ratio  1 time
In silico  1 time
Immunoglobulin M  1 time
Immunoglobulin G  1 time
Immunoglobulin A  1 time
Hydrophile  1 time
Humoral immunity  1 time
Humerus  1 time
Hospital readmission  1 time
Hoffmann-La Roche  1 time
Hematopoietic stem cell transplantation  1 time
Haplotype  1 time
Growth factor  1 time
Glutathione  1 time
Gastrointestinal tract  1 time
Gastrectomy  1 time
Fluorescence microscope  1 time
Flow cytometry  1 time
Fever  1 time
Femur  1 time
Exon  1 time
Excipient  1 time
Eutectic system  1 time
Estrogen receptor  1 time
Erlotinib  1 time
Epithelium  1 time
Epinephrine  1 time
Eosinophilia  1 time
Edema  1 time
Disease  1 time
Diarrhea  1 time
DNA  1 time
Cytotoxic T cell  1 time
Cytokine  1 time
Colorectal cancer  1 time
Colonoscopy  1 time
ClinicalTrials.gov  1 time
Chromosome  1 time
China  1 time
Chemotherapy regimen  1 time
Cell-mediated immunity  1 time
Cell potency  1 time
Carcinoma  1 time
Carbohydrate  1 time
CTLA-4  1 time
CD135  1 time
CD117  1 time
Breast cancer  1 time
Bone marrow examination  1 time
Biomarker  1 time
Bevacizumab  1 time
Beta-catenin  1 time
B cell  1 time
Antimony trioxide  1 time
Antigen presentation  1 time
Antigen  1 time
Antibody  1 time
Anemia  1 time
Anaphylaxis  1 time
Allele  1 time
Adjuvant therapy  1 time
Adenosine triphosphate  1 time
Adenocarcinoma  1 time
Acid  1 time
Abdominoperineal resection  1 time
ATP-binding cassette transporter  1 time
18 Months  1 time

Publications tagged with this subject: 37

Note: Top 50 publications shown only. Open an item panel to view more info




Questions?

Drop us a message.